Annual EBITDA
$14.58B$1.16B+8.60%
Summary
- Current Value
- As of today, GILD annual EBITDA is $14.58B, up +8.60% on
- Historical Performance
- GILD annual EBITDA is up +13.39% over the past 3 years, up +22.29% over the past 5 years
- All-Time High Comparison
- GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on
- 3-Year Low Comparison
- GILD annual EBITDA is +17.25% above its 3-year low of $12.44B reached on
- Sector Comparison
- GILD annual EBITDA is higher than 98.76% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $14.58B | +8.6% | +13.4% | +22.3% | +248.9% | |
| Quarterly EBITDA | $4.27B | +1.2% | +26.2% | -2.2% | +280.6% | |
| TTM EBITDA | $14.72B | +4.4% | +22.1% | +3.2% | +257.5% | |
| Price | $170.68 | +44.1% | +119.5% | +163.1% | +697.8% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $29.45B | +2.5% | +8.7% | +19.5% | +273.9% | |
| Annual EPS | $6.78 | +1672.8% | +86.4% | +6861.9% | +308.3% | |
| Annual EBIT | $11.82B | +10.8% | +9.8% | +13.2% | +201.9% | |
| Annual Net Income | $8.51B | +1672.9% | +86.4% | +9461.8% | +194.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $14.58B | at high | |
| 5Y | $14.58B | at high | |
| All | $22.69B | -35.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $12.44B | +17.3% | |
| 5Y | $11.92B | N/A | +22.3% |
| All | -$104.60M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of GILD?
- As of today, GILD annual EBITDA is $14.58B
- What is 1-year change in GILD annual EBITDA?
- GILD annual EBITDA is up +8.60% year-over-year
- What is 3-year change in GILD annual EBITDA?
- GILD annual EBITDA is up +13.39% over the past 3 years
- How far is GILD annual EBITDA from its all-time high?
- GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on December 31, 2015
- How does GILD annual EBITDA rank versus sector peers?
- GILD annual EBITDA is higher than 98.76% of companies in Healthcare sector
- When is GILD next annual earnings release?
- The next annual earnings release for GILD is on
EBITDA Formula
Quarterly EBITDA
$4.27B$922.00M+27.57%
Summary
- Current Value
- As of today, GILD quarterly EBITDA is $4.27B, up +27.57% on
- Historical Performance
- GILD quarterly EBITDA is up +1.21% year-over-year, up +26.21% over the past 3 years
- All-Time High Comparison
- GILD quarterly EBITDA is currently -26.05% below its historical high of $5.77B set on
- 3-Year Low Comparison
- GILD quarterly EBITDA is +42.58% above its 3-year low of $2.99B reached on
- Sector Comparison
- GILD quarterly EBITDA is higher than 98.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $4.27B | +27.6% | +1.2% | +26.2% | -2.2% | |
| Annual EBITDA | $14.58B | – | +8.6% | +13.4% | +22.3% | |
| TTM EBITDA | $14.72B | +0.3% | +4.4% | +22.1% | +3.2% | |
| Price | $170.68 | +30.0% | +44.1% | +119.5% | +163.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $8.30B | +6.2% | +6.7% | +18.0% | +11.6% | |
| Quarterly EPS | $1.94 | +123.0% | -20.2% | +11.9% | -5.5% | |
| Quarterly EBIT | $3.53B | +33.3% | -0.1% | +30.8% | -9.2% | |
| Quarterly Net Income | $2.43B | +123.1% | -20.4% | +11.8% | -6.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.27B | at high | |
| 3Y | $4.27B | at high | |
| 5Y | $4.36B | N/A | -2.2% |
| All | $5.77B | -26.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.34B | +27.6% | |
| 3Y | $2.99B | +42.6% | |
| 5Y | $2.00B | +113.5% | |
| All | -$1.16B | +468.7% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of GILD?
- As of today, GILD quarterly EBITDA is $4.27B
- What is GILD quarterly EBITDA most recent change?
- GILD quarterly EBITDA was up +27.57% on September 30, 2026
- What is 1-year change in GILD quarterly EBITDA?
- GILD quarterly EBITDA is up +1.21% year-over-year
- How far is GILD quarterly EBITDA from its all-time high?
- GILD quarterly EBITDA is currently -26.05% below its historical high of $5.77B set on June 30, 2015
- How does GILD quarterly EBITDA rank versus sector peers?
- GILD quarterly EBITDA is higher than 98.84% of companies in Healthcare sector
- When is GILD next earnings release?
- The next earnings release for GILD is on
EBITDA Formula
TTM EBITDA
$14.72B$51.00M+0.35%
Summary
- Current Value
- As of today, GILD TTM EBITDA is $14.72B, up +0.35% on
- Historical Performance
- GILD TTM EBITDA is up +4.36% year-over-year, up +22.06% over the past 3 years
- All-Time High Comparison
- GILD TTM EBITDA is currently -35.32% below its historical high of $22.76B set on
- 3-Year Low Comparison
- GILD TTM EBITDA is +23.88% above its 3-year low of $11.88B reached on
- Sector Comparison
- GILD TTM EBITDA is higher than 98.94% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $14.72B | +0.3% | +4.4% | +22.1% | +3.2% | |
| Annual EBITDA | $14.58B | – | +8.6% | +13.4% | +22.3% | |
| Quarterly EBITDA | $4.27B | +27.6% | +1.2% | +26.2% | -2.2% | |
| Price | $170.68 | +30.0% | +44.1% | +119.5% | +163.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $31.06B | +1.7% | +6.9% | +13.9% | +12.7% | |
| TTM EPS | -$3.15 | -18.5% | -148.8% | -167.5% | -153.7% | |
| TTM EBIT | $11.93B | -0.0% | +5.2% | +25.2% | -3.2% | |
| TTM Net Income | -$3.86B | -19.2% | -147.6% | -166.3% | -152.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $14.77B | -0.3% | |
| 3Y | $14.77B | -0.3% | |
| 5Y | $14.77B | -0.3% | |
| All | $22.76B | -35.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.10B | N/A | +4.4% |
| 3Y | $11.88B | +23.9% | |
| 5Y | $11.88B | +23.9% | |
| All | -$104.60M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of GILD?
- As of today, GILD TTM EBITDA is $14.72B
- What is GILD TTM EBITDA most recent change?
- GILD TTM EBITDA was up +0.35% on September 30, 2026
- What is 1-year change in GILD TTM EBITDA?
- GILD TTM EBITDA is up +4.36% year-over-year
- How far is GILD TTM EBITDA from its all-time high?
- GILD TTM EBITDA is currently -35.32% below its historical high of $22.76B set on December 31, 2015
- How does GILD TTM EBITDA rank versus sector peers?
- GILD TTM EBITDA is higher than 98.94% of companies in Healthcare sector
- When is GILD next earnings release?
- The next earnings release for GILD is on
EBITDA Formula
Data Sources & References
- GILD Official Website www.gilead.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
- GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild
